In compliance with current regulations, let us know which audience you belong to:
Helping people, through science.
That’s our mission and our pride.
Shaping the future of care through innovation, we are committed to redefining paradigms in ophthalmology and beyond, empowering our partners and their patients with the best, certified medical technologies.
Espansione Group delivers the highest standards in medtech by combining proprietary technologies, like LM® LLLT photobiomodulation, with a relentless focus on research, development, and customer excellence. With a global presence in over 50 countries, we aim to transform care in ophthalmology and beyond.
eye-light® Device is Granted CE (MDR) Mark for Treatment of Dry AMD and Extended Anterior Segment Pathologies
Unlocking New Horizons with Photobiomodulation from the Front to the Back of the Eye
Our technologies are at the very core of the Espansione Ecosystem—they leverage the power of light and its outstanding ability to benefit the human condition.
They are then seamlessly built into all our solutions, from diagnosis to treatment. We design, craft and test with the greatest attention and care in Italy.
Ecosystem is the term we use to describe the synergy between our technologies and the solutions that leverage on them. Every interaction within the Espansione Ecosystem has been designed to provide both patients’ and operators’ with the best experience possible.
The latest, from us. Publications,
press releases, and more.
We take pride in having built great partnerships throughout the years with some of the greatest players in the healthcare industry.
Our scientific discoveries and our entrepreneurial successes have been featured in the best outlets worldwide.
Scientific publications on our technology